- ACA stands: Supreme Court rules law is a tax
- Former CMS, FDA chief McClellan to headline Cardinal Health RBC business program
- Medication therapy management contribution to improved outcomes and cost savings in health care
- Walgreens selected by CMS to be an enteral nutrition provider in most competitive-bidding areas
- CMS decision on diabetes-testing supplies would disrupt care, members of Congress say
PITTSBURGH — Generic drug maker Mylan has settled a lawsuit concerning Medicaid reimbursements with the federal government and the state of Texas, Mylan said Dec. 24.
Under the settlement, Mylan will pay $65 million.
Several state attorneys general filed lawsuits against Mylan and other drug companies in September 2003 over Medicaid reimbursements, alleging that the companies defrauded the programs by reporting average wholesale prices greater than the prices of their prescription drugs, thus causing the programs to make excessive payments to healthcare providers.